Navigation Links
ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors
Date:6/23/2008

A>.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, including but not limited to statements made relating to the value of our products in the marketplace, our ability to develop and market our technologies and commercialization of products in the marketplace. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2007, Quarterly Report on Form 10-Q for the quarter ended March 31, 2008 and other reports filed by us with the Securities and Exchange Commission.

Contact: Company

Kerry P. Gray

President & CEO

Terry K. Wallberg

Vice President & CFO

(214) 905-5145


'/>"/>
SOURCE ULURU Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ULURU Inc. to Present at UBS Global Life Sciences Conference 2007
2. ULURU Inc. Announces Odd-Lot Buy Back Offer
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2007 and Provide a Business Update
4. ULURU Inc. Reports Third Quarter 2007 Results
5. ULURU Inc. Announces Issuance of Notice of Allowance for Nanoparticle Aggregate Patent
6. ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
7. ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2008 and Provide a Business Update
8. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter Ended December 31, 2007 and Provide a Business Update
9. ULURU Inc. Announces the Launch Plan for Altrazeal(TM)
10. ULURU Inc. Reports First Quarter 2008 Financial Results
11. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...errorism in India precedes the recent coordinated ...GTD), maintained at the University of Maryland by ... and Responses to Terrorism (START) counts more th...talities number in the thousands. This information...st comprehensive and detailed open-source terroris...
(Date:12/2/2008)... EIN News has announced the launch of a new health..., , With new advances in medicine, more and ...one of the key components to surviving cancer. ,...urate information about lung cancer, its risk fact...IN News is introducing Lung Cancer News Today to o...
(Date:12/2/2008)...e-USNewswire/ -- Fatigued medical residents need p...f work hour limits to improve patient safety and t...ute of Medicine report funded by HHS, Agency for H...port is the result of a 15-month study by an IOM c...sidents, work schedules, their performance and the...
(Date:12/2/2008).../ -- VirtualScopics, Inc.,(Nasdaq: VSCP ), a le...l,trials, today announced that its backlog curren... at the same time a year ago, a greater than 80%,...ount remaining to be,recognized from active and a...luded within the backlog ranges from 2 months to 6...
Breaking Medicine News(10 mins):Health News:India terrorism by the numbers 2Health News:EIN News Introduces 'Lung Cancer News Today'; Website Offers Information on Risk Factors, Treatment, Drugs 2Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 2Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 3Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 4Health News:VirtualScopics Backlog Rises to a Record $27 Million 2Health News:VirtualScopics Backlog Rises to a Record $27 Million 3
...odernization, the Stress on human life has been in...tion to the adoption of a more healthy and peacef...those people with fragile hearts.Most of us get an...But this one moment of anger is sufficient enough ...
...ination of drugs for Hepatitis -C Cures more patie...tment for the potentially deadly,liver destroying ...a more potent weapon against the virus at a time e... of Hepatitis- C liver damage over the next few ye...
...rm connection between viral infection and pre-canc... shown that infection with human papillomavirus (H... group of almost 8,500 women with no history of ab...wed for ten years. They had a cervical smear at th...
...rved that Opioid analgesics should be considered b...in. The opioid analgesics, such as morphine, fenta...t often used to relieve cancer pain. But a review ... have a role in relieving chronic back pain. Doct...
Other Medicine News:
(Date:12/1/2008)...wswire-USNewswire/ -- New research has found that ...d tomography (CT) scanner in an emergency room can...ms who receive a potentially life-saving treatment...edical Center (NSMC)-Salem Hospital in Salem, Mass...f the Radiological Society of North America (RSNA)...
(Date:12/1/2008)... Roche announced today that a,comp... perceived pain and,discomfort associated with bl...e monitoring systems and lancing devices were deem... overall, the ACCU-CHEK Aviva and ACCU-CHEK Compac...CCU-CHEK Multiclix, ACCU-CHEK,Softclix and ACCU-C...
(Date:12/1/2008)...k, December 1 Following ...tent to procure an MVA-based,third generation sm...es,Canada, on behalf of the Canadian Department o...arian Nordic for the delivery of IMVAMUNE(R). , ...NE(R) as part of the,country,s bio-preparedness p...
(Date:11/30/2008)...wswire-USNewswire/ -- Abnormalities in auditory an... with autism spectrum disorder by using magnetoenc... today at the annual meeting of the Radiological S...MEG, we can record the tiny magnetic fields associ... Roberts, Ph.D., vice chair of research in the Dep...
Breaking Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3WellPoint Awarded Prestigious International Marketing Award 28275 1WellPoint Awarded Prestigious International Marketing Award 28275 2Webcast Alert 3A Air Methods Corporation Announces Third Quarter 2008 Financial Results 28272 1Green Makeup Artist Paige Padgett Says Get Smart 8753 1Green Makeup Artist Paige Padgett Says Get Smart 8753 2First evidence that prenatal exposure to famine may lead to persistent epigenetic changes 28269 1First evidence that prenatal exposure to famine may lead to persistent epigenetic changes 28269 2First evidence that prenatal exposure to famine may lead to persistent epigenetic changes 28269 3
...eceiving highest dose,achieves A1c with no associa...re-FirstCall/ -- According to,findings presented t...an Diabetes Association (ADA) in Chicago, Illinois...e- daily dose of human,GLP-1 analog under developm...abetes significantly improved glycemic control (A1...
...se Homeostasis Effects in,Normal and Diabetic Rats... -- In a 14-day,Phase IIa study of the safety pro...ound dapagliflozin, a selective inhibitor of,the S...lone or,concomitantly with metformin in subjects w...verse events and no serious adverse,events were re...
Other Medicine Technology:Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog,Liraglutide, Brings Patients to A1c Target 2Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog,Liraglutide, Brings Patients to A1c Target 3Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog,Liraglutide, Brings Patients to A1c Target 4First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 2First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 3First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 4First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 5First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 6
...ginal Vibratome Semi-Automatic Tissue Sectioning S...d tissue sectioning system. Researchers from aroun...sic for their fresh and fresh fixed tissue section...Automatic Tissue Sectioning Systems, the biologica...
...ratome 1000 Plus Sectioning System provides a vers...or plant tissues. The 1000 employs a vibrating bl...zing or embedding. The creation of artifacts, the...me activities, and other deleterious effects inher...
The Vibratome comes standard with a square vice mounting device. These specimen blocks are utilized for mounting specimens and placing in the Vibratome holding vice. The blocks are annodized black
This is a perfect tool for retrieving free floating sections from the Vibratome bath.
Medicine Products: